Trial Profile
An Open-label, Multiple Dose Study to Assess the Pharmacokinetic Profile of Minocycline From FMX-101 Foam (4%) in Male and Female Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 May 2021
Price :
$35
*
At a glance
- Drugs Minocycline (Primary)
- Indications Acne vulgaris
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Foamix
- 30 Sep 2014 New trial record